More PRNewswire
View Older Stories View Newer Stories-
Smartee Pioneers a New Phase in Orthodontics with Silicon Valley Founder Mode
-
Entrepreneur Universe Bright Group Announces Audited Financial Results for Fiscal Year Ended December 31, 2024
-
"Neo-Chinese Style" Launches: Spotlight on Traditional Chinese Couture on the Global Stage
-
SAMARITAN'S PURSE RESPONDS TO DEADLY EARTHQUAKE IN MYANMAR; AIRLIFTING EMERGENCY FIELD HOSPITAL AND LIFE-SAVING SUPPLIES
-
TutorABC Expands Leadership Team to Drive Global Growth in Language Learning and Livestreaming E-Commerce Innovation
-
Innovent Receives NMPA Breakthrough Therapy Designation for IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Melanoma
-
Pudu Robotics Unveils FlashBot Arm: A Semi-Humanoid Embodied AI Service Robot for Commercial Applications
-
Global Times: Readers' Reflections: Outside observers underestimate the profound connection between the Party and people, says Somali Ambassador to China
-
BOC Aviation Orders 50 Boeing 737 MAX Jets to Support Global Airlines
-
Monster Energy Freeski and Snowboard Athletes Claim Victories at the 2025 FIS Snowboard and Freeski World Championships in Switzerland
-
Monster Energy's Brandon Moreno Defeats Steve Erceg at UFC Mexico City
-
Li-S Energy collaborates with Kea Aerospace to power high altitude UAV flights
-
CNOOC Limited Announces A Hundred-Million-Ton Oilfield Discovery of Huizhou 19-6
-
Else Nutrition Reschedules 2024 Fiscal Year Business Update Conference Call
-
Akeso's 2024 Results: Strengthening Global Competitiveness and Transforming the Treatment Landscape with Bispecific Antibodies
-
Lilly's lepodisiran reduced levels of genetically inherited heart disease risk factor, lipoprotein(a), by nearly 94% from baseline at the highest tested dose in adults with elevated levels
-
Global Times: Practitioners' Insights: Practice of 'feedback window for unfinished work' in Anji showcases CPC's people-centric approach
-
Medtronic Evolut™ TAVR system shows durable clinical outcomes and outstanding valve performance at five years in low-risk aortic stenosis patients
-
Coolidge National Medal of Honor Heritage Center Celebrates Opening of Captain Larry L. Taylor Exhibit
-
Martin Guitar & Eric Clapton Celebrate 30 Years of Collaboration with New Limited-Edition Guitars
-
Congress Majority PAC spending $120,000 on a unique anti-Trump ad buy in two House races in Florida holding special elections April 1st
-
SCORE analysis of semaglutide 2.4 mg demonstrated reduction in cardiovascular events in a real-world setting
-
Boston-Based Restaurant Blends Seafood and Self-Care with Lobster Roll Lip Gloss
-
Fosun International Announces 2024 Annual Results: Total Revenue Reaches RMB192.14 Billion, Industrial Operation Profit Amounts to RMB4.9 Billion, Overall Operational Fundamentals Remain Stable
-
PetroChina Posts Sustained Growth in 2024, Achieving Third Consecutive Year of Record-Breaking Performance
-
BFA's 10th Religious Sub-forum Highlights Global Digitization Project of Buddhist Scriptures
-
Kristin Chenoweth and Mediaplanet Empower the Future Through Arts Education
-
Brii Bio Unveils New Data from Its Ongoing Phase 2 ENSURE Study at APASL 2025, Showcasing BRII-179's Unique Potential to Prime and Boost Higher HBsAg Loss Through Target Patient Identification
-
Tourism Plus Shanghai 2025, a Key Innovation Hub of Global Tourism Industry, to Break Record with its Scale
-
Think you can do better than your team's GM? Ultra GM gives you that chance.
-
Family of Yuyu Dong (outside of China) Available After Appeals Hearing Monday
-
Oral semaglutide 14 mg demonstrated superior reduction in risk of cardiovascular events in late-breaking SOUL trial presented at the American College of Cardiology
-
With Renovation Approaching, Final Dubai Fountain Show Date Unveiled
-
Explore the 2025 Ford Bronco Trim Level Research: Find Your Perfect Off-Road Adventure Companion at Akins Ford near Atlanta, GA
-
How Medical Malpractice Cases Work in Florida: What Victims Need to Know
-
Ozempic® (semaglutide) injection 1 mg showed improved functional outcomes and health-related quality of life in Phase 3 STRIDE trial in adults with type 2 diabetes and peripheral artery disease (PAD)
-
JASPER Celebrates 5 Years of Excellence in Luxury Home Building and Renovation in Nashville, TN
-
Eoptolink Launches 1.6T OSFP 2VR4 Transceivers Using 200G VCSELs
-
Eoptolink Launches its Gen2 1.6T OSFP and OSFP-RHS Transceiver Family at OFC 2025
-
Omega World Travel's Commitment to Women's Leadership
-
KIIT Expands Global Presence Through Strategic Academic Collaborations
-
Accelerating Connectivity in the Asia-Pacific: ADC Submarine Cable Empowers the Digital Future
-
LONGi Chairman Zhong Baoshen Attends Boao Forum for Asia: Continuously Deepening China-Australia Tech Collaboration in Clean Energy
-
Redefining the transistor: The ideal building block for artificial intelligence
-
BRI Holds 2025 Annual General Meeting of Shareholders (AGMS), Distributes IDR 51.73 Trillion in Dividends and Prepares for IDR 3 Trillion Buyback
-
Zylox-Tonbridge Announces 2024 Annual Results: Achieves Full-Year Profit for the First Time with Net Profit Exceeding USD 14 Million
-
VOA Journalists Receive Career Support From Press Freedom Center Today
-
JEGI CLARITY Has Advised Ai4 on Their Sale to CloserStill Media
-
WELL Health Announces Delay in Filing of Annual Audited Financial Statements Due to Matter Related to US Subsidiary Circle Medical
-
DriveTime Partners with Girl Gang Garage to Donate Van to Maggie's Place
